Drugs / AM1030
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02379910 | Nov 2014 → Jun 2015 | atopic eczema | AnaMar AB | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AM1030 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02379910 ↗ |
| Route | Topical | “A Phase I/II, Double-Blind, Placebo-Controlled, Single and Multiple Ascending (Topical) Dose” NCT02379910 ↗ |